
USD $23.08
ARIXTRA (Fondaparinux Sodium) is an anticoagulant medication that is used to prevent and treat blood clots. This injection is specifically designed for patients at risk of thromboembolic events, including those who have undergone certain surgical procedures or are experiencing deep vein thrombosis (DVT) or pulmonary embolism (PE).
ARIXTRA INJECTION 2.5mg/0.5ml is a medication that contains Fondaparinux Sodium, an anticoagulant used to prevent and treat blood clots. It works by inhibiting factor Xa in the coagulation cascade, which helps to reduce the formation of harmful clots.
The typical dosage for ARIXTRA is 2.5 mg administered subcutaneously once daily. Dosage may vary based on the patient's condition, age, and weight. Always follow the prescribing physician's instructions for the correct dosage.
Common side effects may include:
If you experience severe side effects or signs of an allergic reaction, seek medical attention immediately.
ARIXTRA is administered as a subcutaneous injection.
Consult your healthcare provider as the use of ARIXTRA during pregnancy should be evaluated on a case-by-case basis.
If you miss a dose, take it as soon as you remember. If it's close to the time of your next dose, skip the missed dose and resume your regular schedule. Do not double the dose.
There are no specific dietary restrictions, but it is essential to inform your doctor about any supplements or other medications you are taking.